CN1246335A - 一种用于治疗皮肤病药物的制作方法 - Google Patents

一种用于治疗皮肤病药物的制作方法 Download PDF

Info

Publication number
CN1246335A
CN1246335A CN 98118157 CN98118157A CN1246335A CN 1246335 A CN1246335 A CN 1246335A CN 98118157 CN98118157 CN 98118157 CN 98118157 A CN98118157 A CN 98118157A CN 1246335 A CN1246335 A CN 1246335A
Authority
CN
China
Prior art keywords
dermatopathya
treat
medicine used
preparing medicine
cinnarizine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98118157
Other languages
English (en)
Inventor
冀聪韬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 98118157 priority Critical patent/CN1246335A/zh
Publication of CN1246335A publication Critical patent/CN1246335A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种用于治疗皮肤病药物的制作方法,其采用以下重量百分比组分:扑尔敏1.5—2%,脑益嗪13—15%,钙片65—70%,强的松2—4%,潘生丁13—15%,以上各组份混合粉碎即成,本发明具有增强毛细血管紧张度,降低血管通透性,加强抗敏、抗感染能力,改善机体代谢和末梢循环,从而具有止痒、消炎、脱敏的功效。

Description

一种用于治疗皮肤病药物的制作方法
本发明涉及一种用来治疗荨麻疹、湿疹、药疹、接触性皮炎及神经性皮炎和脂溢性皮炎引起的皮肤瘙痒一种新的行之有效的口服复方药。
荨麻疹、湿疹、药疹、接触性皮炎等皮肤病在日常生活中十分常见,其病因主要是由于内、外刺激因素作用于机体而引起的皮肤变态反应,引起体内组织胺的释放,使皮肤血管扩张,血管壁通透性增强,因而产生红肿、红斑、风团及周围红晕,甚至水疱等皮损,并刺激感觉神经末梢,产生皮肤瘙痒,往往因抓痒而形成糜烂等,甚或继发感染等症状,给患者带来很大痛苦和诸多不便。但目前临床上常用抗组织胺药(如敏迪、扑尔敏等)、钙剂(如葡萄糖酸钙)或加少许的激素进行治疗,目前还没有一种专门治疗而行之有效的药品。
本发明的目的在于提供一种具有止痒、消炎、脱敏、消斑的功效且作用迅速、抗敏力强、疗效高的药物复方肤康宁。
本发明的目的是这样实现的:采用以下重量百分比组份:扑尔敏1.5-2%,脑益嗪13-15%,钙片65-70%,强的松2-4%,潘生丁13-15%,将以上各组份混合粉碎即成。
本发明具有增强毛细血管紧张度、降低血管通透性、减少渗出、加强抗敏抗感染能力,改善末梢循环和机体代谢,抑制血小板凝集的作用,从而具有止痒、消炎、脱敏、消斑的功效,其作用迅速、抗敏力强,疗效高,用药需注意:孕妇及哺乳期妇女忌用,急性心梗、前列腺肥大患者慎用。
几年来,经大量临床应用,对数百例患者进行疗效观察,结果表明总有效率达95.65%。
                                   疗效观察表
病名     荨麻疹    湿疹     药疹  接触性皮炎   神经性皮炎
经治疗人数     158     38      13     26     18
有效率     98.73%     92.11%      84.62%    92.31%     83.33%
本发明实施例如下表所示:
组  份                  含量(%)
扑尔敏     1.5     2     1.7
脑益嗪     13     14     15
钙  片     70     67     65.3
强的松     2.5     2     4
潘生丁     13     15     14
合  计     100     100     100

Claims (1)

1、一种用于治疗皮肤病药物的制作方法,其特征在于采用以下重量百分比组份:扑尔敏1.5-2%,脑益嗪13-15%,钙片65-70%,强的松2-4%,潘生丁13-15%,以上各组份混合粉碎即成。
CN 98118157 1998-08-28 1998-08-28 一种用于治疗皮肤病药物的制作方法 Pending CN1246335A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 98118157 CN1246335A (zh) 1998-08-28 1998-08-28 一种用于治疗皮肤病药物的制作方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 98118157 CN1246335A (zh) 1998-08-28 1998-08-28 一种用于治疗皮肤病药物的制作方法

Publications (1)

Publication Number Publication Date
CN1246335A true CN1246335A (zh) 2000-03-08

Family

ID=5225929

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98118157 Pending CN1246335A (zh) 1998-08-28 1998-08-28 一种用于治疗皮肤病药物的制作方法

Country Status (1)

Country Link
CN (1) CN1246335A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253155B2 (en) 2001-10-05 2007-08-07 Combinatorx, Inc. Combinations for the treatment of immunoinflammatory disorders
US8080553B2 (en) 2003-10-15 2011-12-20 Zalicus Inc. Methods and reagents for the treatment of immunoinflammatory disorders

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253155B2 (en) 2001-10-05 2007-08-07 Combinatorx, Inc. Combinations for the treatment of immunoinflammatory disorders
CN100400044C (zh) * 2001-10-05 2008-07-09 康宾纳特克斯公司 制备治疗免疫炎性疾病的联合药物的用途
US7915265B2 (en) 2001-10-05 2011-03-29 Zalicus Inc. Combinations for the treatment of immunoinflammatory disorders
US8080553B2 (en) 2003-10-15 2011-12-20 Zalicus Inc. Methods and reagents for the treatment of immunoinflammatory disorders

Similar Documents

Publication Publication Date Title
ES2202326T3 (es) Uso de cetoconazol y sustancias relacionadas en medicamentos para el tratamiento de la diabetes de tipo ii.
JPS60100517A (ja) 放射線潰瘍治療剤および方法
US20060240119A1 (en) Pharmacologically active strong acid solutions
CN1246335A (zh) 一种用于治疗皮肤病药物的制作方法
Semeniv et al. The experience of Antennaria dioica application in folk medicine and prospects of this plant use for creation of new phytohemostatics
CN112076269A (zh) 一种治疗心血管疾病的辅助药品
RU2356548C1 (ru) Фармацевтическя композиция для профилактики и лечения климактерических расстройств для местного и наружного применения на основе сигетина
RU2774074C1 (ru) Средство для лечения диффузной фиброзно-кистозной мастопатии у кошек
US7553829B2 (en) Treatment of chronic fatigue syndrome and fibromyalgia syndrome
CN113577090B (zh) 牛蒡子苷在制备前列腺增生药物中的应用
CN1175836C (zh) 一种治疗痔疮的药物
US10953063B2 (en) Method of treating select cancers using timed administration of plant extract from species Physalis pubescens and Hedyotis diffusa willd
RU2245144C1 (ru) Способ лечения местно-распространенных злокачественных опухолей полости носа, околоносовых пазух и носоглотки
KR20070030246A (ko) 자궁 종양 치료용 약제의 제조를 위한7-티-부톡시이미노메틸캄토테신의 용도
RU2271203C1 (ru) Способ лечения синдрома хронической тазовой боли, обусловленного заболеваниями предстательной железы или мочевого пузыря
RU2132187C1 (ru) Способ лечения заболеваний кожи и слизистых оболочек и магнитоактивное органическое соединение железа, используемое в нем
CN101422489A (zh) 一种治疗腺癌的中药制剂
RU2238739C2 (ru) Способ лечения нефропатии у детей в неонатальном периоде
SU1623658A1 (ru) Способ лечени ограниченной склеродермии у женщин
RU2595818C1 (ru) Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
RU2070030C1 (ru) Способ лечения воспалительных заболеваний челюстно-лицевой области у больных сахарным диабетом
CN1969880A (zh) 一种治疗脚气病的药粉
CORMIA Chlorothiazide in acne
SU1346161A1 (ru) Способ лечени хронических воспалительных заболеваний придатков матки
Heath Pyoderma gangrenosum in an elderly woman: Course marked by extensive morbidity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication